385 related articles for article (PubMed ID: 31229399)
61. A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Li J; Ren J; Sun W
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():13-21. PubMed ID: 27923166
[TBL] [Abstract][Full Text] [Related]
62. Metformin in polycystic ovary syndrome: systematic review and meta-analysis.
Lord JM; Flight IH; Norman RJ
BMJ; 2003 Oct; 327(7421):951-3. PubMed ID: 14576245
[TBL] [Abstract][Full Text] [Related]
63. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
Misso ML; Costello MF; Garrubba M; Wong J; Hart R; Rombauts L; Melder AM; Norman RJ; Teede HJ
Hum Reprod Update; 2013; 19(1):2-11. PubMed ID: 22956412
[TBL] [Abstract][Full Text] [Related]
64. Effects of GLP-1 on ovarian dysfunction in polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
Zhang C; Yan D; Wang X; Cheng D
Medicine (Baltimore); 2023 Jan; 102(2):e32312. PubMed ID: 36637917
[TBL] [Abstract][Full Text] [Related]
65. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
66. Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis.
Xu Y; Wu Y; Huang Q
Arch Gynecol Obstet; 2017 Oct; 296(4):661-677. PubMed ID: 28770353
[TBL] [Abstract][Full Text] [Related]
67. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
[TBL] [Abstract][Full Text] [Related]
68. A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.
Sathyapalan T; Cho LW; Kilpatrick ES; Coady AM; Atkin SL
Clin Endocrinol (Oxf); 2008 Dec; 69(6):931-5. PubMed ID: 18410553
[TBL] [Abstract][Full Text] [Related]
69. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
70. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
71. Metformin and glitazones: do they really help PCOS patients?
Pillai A; Bang H; Green C
J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254
[TBL] [Abstract][Full Text] [Related]
72. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Clin Endocrinol (Oxf); 2022 Jun; 96(6):758-780. PubMed ID: 34918367
[TBL] [Abstract][Full Text] [Related]
73. Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations--introductory report.
Marciniak A; Nawrocka-Rutkowska J; Brodowska A; Sienkiewicz R; Szydłowska I; Starczewski A
Folia Histochem Cytobiol; 2009; 47(2):323-8. PubMed ID: 19995720
[TBL] [Abstract][Full Text] [Related]
74. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis.
Graff SK; Mario FM; Ziegelmann P; Spritzer PM
Int J Clin Pract; 2016 Jun; 70(6):450-61. PubMed ID: 27228266
[TBL] [Abstract][Full Text] [Related]
75. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
[TBL] [Abstract][Full Text] [Related]
76. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
[TBL] [Abstract][Full Text] [Related]
77. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
[TBL] [Abstract][Full Text] [Related]
78. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
[TBL] [Abstract][Full Text] [Related]
79. Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.
Kashyap S; Wells GA; Rosenwaks Z
Hum Reprod; 2004 Nov; 19(11):2474-83. PubMed ID: 15358717
[TBL] [Abstract][Full Text] [Related]
80. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
